Construct and Predictive Validity of the Kansas City Cardiomyopathy Questionnaire in Adult Congenital Heart Disease [0.03%]
成人先天性心脏病患者堪萨斯城心肌病问卷的构建和预测效度
Ryan D Byrne,Ajith P Nair,Stephen J Dolgner et al.
Ryan D Byrne et al.
Background: The Kansas City Cardiomyopathy Questionnaire (KCCQ) is an Food and Drug Administration-approved health status measure for patients with heart failure (HF) but has not been directly assessed in adult congenital...
Assessing Cardiomyocyte DNA Damage Using Cardiovascular Magnetic Resonance T1 Mapping: Insights From Comparative Biopsy Analysis [0.03%]
基于比较活检分析的心肌细胞DNA损伤的磁共振T1图评估研究
Mizuki Ichikawa,Shiro Nakamori,Masaki Ishida et al.
Mizuki Ichikawa et al.
Background: DNA damage in cardiomyocytes is a key pathological pathway in heart failure progression. It is a reversible process that precedes apoptosis and fibrosis. However, the utility of cardiovascular magnetic resonan...
Comparing Claims Data to Stroke and Bleeding in the NCDR Left Atrial Appendage Occlusion Registry [0.03%]
基于NCDR左心耳封堵注册研究比较医保数据所得卒中及出血并发症评分标准
Kamil F Faridi,James V Freeman,Yongfei Wang et al.
Kamil F Faridi et al.
Background: Claims data are increasingly used for postmarketing surveillance of therapies such as transcatheter left atrial appendage occlusion (LAAO), but their accuracy remains uncertain. ...
Coronary Artery Disease-Based Polygenic Risk Score in Early-Onset Acute Myocardial Infarction Subtypes [0.03%]
冠状动脉疾病多基因风险评分在早发急性心肌梗死亚型中的应用
Weilai Dong,Yuan Lu,Shu-Xia Li et al.
Weilai Dong et al.
Background: The coronary artery disease-based polygenic risk score (PRS-CAD) estimates risk of acute myocardial infarction (AMI), but its performance across AMI subtypes in younger individuals, especially women, remains u...
Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex [0.03%]
性别对B型利钠肽与死亡和住院结局关联的影响的修正分析：来自三个队列的研究
David Bobrowski,Husam Abdel-Qadir,Candace D McNaughton et al.
David Bobrowski et al.
Background: The effects of sex on the prognostic implications of natriuretic peptide (NP) elevation have not been fully elucidated in the population. Obje...
SGLT2 Inhibitor Treatment Is Associated With Reduced Cardiac Glucose Metabolism: A Matched FDG-PET Cohort Study [0.03%]
SGLT2抑制剂治疗与心脏葡萄糖代谢降低相关：一项匹配的FDG-PET队列研究
Brett W Sperry,Yazan Almohtasib,Ramy Ghaly et al.
Brett W Sperry et al.
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) have cardioprotective effects without acting directly on the myocardium. Objectives: ...
The Mayo Adult Congenital Heart Disease (MACHD) Registry and Biobank [0.03%]
梅奥成人先天性心脏病（MACHD）登记处和生物样本库
Alexander C Egbe,William R Miranda,Heidi M Connolly
Alexander C Egbe
The long-term survival of patients born with congenital heart disease (CHD) has increased significantly over time, and as a result, there are more adults living with CHD than children. In spite of the improvement in the long-term survival o...
Phenotypic Presentation and Longitudinal Characterization of Hereditary ATTRv Amyloidosis in Previously Undiagnosed Family Members [0.03%]
家族中此前未诊断成员的遗传性ATTRv淀粉样变性的表型表现和纵向特征刻画
Luca Fazzini,Matteo Castrichini,Yan Li et al.
Luca Fazzini et al.
Background: Clinical characteristics, cardiac disease progression, and outcomes of "previously undiagnosed" family members of patients with hereditary transthyretin amyloid cardiomyopathy (ATTRv-CM) with pathogenic or lik...
Association of Lipoprotein(a) With Cardiovascular and Cerebrovascular Disease in a Nationally Representative Cohort of Germany [0.03%]
德国全国代表性队列中脂蛋白(a)与心血管和脑血管疾病的相关性研究
Gloria G Gelfert,Ulrike Grittner,Ronny Kuhnert et al.
Gloria G Gelfert et al.
Background: Population-based data on the distribution of lipoprotein(a) (Lp[a]) within the German population are lacking. Objectives: T...
Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR, An Open-Label RCT [0.03%]
急性心肌梗死后左心室血栓口服利伐沙班对比华法林：一项开放标签随机对照研究（RIVAWAR研究）
Jehangir Ali Shah,Jamil Hussain,Bashir Ahmed et al.
Jehangir Ali Shah et al.
Background: Vitamin K antagonists, such as warfarin, are the standard treatment for left ventricular thrombus (LVT). However, direct oral anticoagulants, such as rivaroxaban, are increasingly being considered due to their...